Yunji Inc. reported unaudited revenue of RMB96.3 million (US$14.2 million) for the six months ended June 30, 2026, down from RMB158.3 million a year earlier. The company attributed the decline to soft consumer spending, its efforts to refine its platform role, greater focus on private-label and organic health products, and changes to its supplier and merchant base. The 12-month repeat purchase rate was 69.15%. Net loss narrowed to RMB72.4 million from RMB100.7 million, while adjusted net loss, a non-GAAP measure excluding share-based compensation, was RMB72.3 million. Yunji had RMB242.1 million in cash, restricted cash and short-term investments at June 30. Management said it remained focused on operating efficiency, margin improvement and long-term profitability.